Andere talen AbbVie Inc.

Aandelen

ABBV

US00287Y1091

Farmaceutische producten

Beurs gesloten - Nyse Andere beurzen 22:00:03 13-02-2026			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
231,50 ^USD	+1,76%		+3,69%	+1,32%

13/02	AbbVie Inc. Presents at Piper Sandler Virtual Novel Targets in Immunology Symposium, Feb-13-2026 10:00 AM
13/02	China Medical University Hospital werkt samen met Ever Supreme Bio Technology aan de ontwikkeling van exosoomplatform	CI

Andere talen

13/02	China Medical University Hospital Collaborates with Ever Supreme Bio Technology to Develop Exosome Platform
12/02	AbbVie sues US health agency over Botox price controls
12/02	West Pharma forecasts 2026 profit above estimates on strong demand for drug components
12/02	West Pharma forecasts 2026 profit above estimates on strong demand for drug components
12/02	West Pharma forecasts 2026 profit above estimates on strong demand for drug components
12/02	West Pharmaceutical Services, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2026
12/02	Bourse : EssilorLuxottica, Hermès et Unibail publient, Sanofi perd sa tête
12/02	Des résultats qui ne pardonnent pas
11/02	AbbVie sues US Health Department over Botox price controls
11/02	AbbVie sues US health agency over Botox
11/02	AbbVie sues U.S. Department of Health and Human Services over selection of Botox for IRA Medicare drug negotiations
05/02	CVS Health to drop Amgen and Lilly's bone disease treatments from some drug lists (February 5)
05/02	Wall Street clôture sans direction claire
04/02	Health Care Up After Eli Lilly Earnings -- Health Care Roundup
04/02	Nasdaq, S&P 500 Fall as Tech Sell-Off Continues
04/02	MÄRKTE USA/Wall Street von KI-Modellen erneut belastet
04/02	Sector Update: Health Care Stocks Rise Late Afternoon
04/02	Sector Update: Health Care Stocks Rise Wednesday Afternoon
04/02	MÄRKTE USA/Wall Street von KI-Modellen belastet
04/02	AbbVie forecasts upbeat 2026 profit, but shares fall on key drug's sales miss
04/02	Boston Scientific, AbbVie Beat Quarterly Views; Shares Slump Amid Weakness in Certain Segments
04/02	En manque de catalyseurs clairs, Wall Street part dans tous les sens
04/02	AbbVie Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025
04/02	AbbVie Q4 Adjusted Earnings, Revenue Rise; 2026 Adjusted Earnings Guidance Issued
04/02	AbbVie forecasts 2026 profit above estimates on strong sales of newer immunology drugs

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripten Persberichten Officiële publicaties Andere talen MarketScreener-artikels MarketScreener-analyses Ideeën voor de handel

Andere talen AbbVie Inc.

Aandelen

ABBV

US00287Y1091

Farmaceutische producten

Andere talen

Filters